Concepedia

M V Blagosklonny

MV

Statistics

Publications

7

Citations

867

H-Index

7

Active since

1994

Affiliations

National Cancer Institute(Current)

Albany Research Institute

M V Blagosklonny is an author at National Cancer Institute specializing in pharmacology, oncology, and chemotherapy.

Publications per year

1994–2008

7

Publications

7

Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.

M V Blagosklonny, Tim Schulte, P Nguyen et al. · PubMed · 1996 · 376 citations

, , +17

Bcl-xL is phosphorylated in malignant cells following microtubule disruption.

Marianne S. Poruchynsky, E E Wang, Charles M. Rudin et al. · PubMed · 1998 · 157 citations

, , +17

A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.

Raymond C. Bergan, E Reed, Catherine E. Myers et al. · PubMed · 1999 · 103 citations

, , +16

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis

Zoya N. Demidenko, Swathi Kalurupalle, Christine Hanko et al. · Oncogene · 2008 · 102 citations

, , +17

Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection

Zoya N. Demidenko, Claire Vivo, H. Dorota Halicka et al. · Cell Death and Differentiation · 2005 · 78 citations · Full text

, , +12

1–5 of 7